MOA, pKa, Vd, onset Flashcards
thiopental
potentiates GABA receptors (agonist)
methohexital
potentiate GABA receptors,
midazolam
facilitate GABA receptors (do not directly activate), pKa 6.15, Vd increases in elderly and obese, onset 30-60 seconds, peak effect 5min, duration 1.9
diazepam
facilitate actions of GABA (ionophores a1, a2, a5). larger Vd in women, crosses placenta. extensively protein bound. >40h half life.
lorazepam
slower onset than midazolam/diazepam. max plasma concentration 2-4h after PO admin. onset 1-2min, increased Vd in obese. peak effect 20-30min IV, duration of sedative effect 6-10hours. half life 14 hours (longer in obese)
flumazenil
competitive benzodiazepine antagonist. reverses in 2 min.
Propofol
selective modulator of GABA (A) receptor. pKa 11. Vd 3.5-4.5L/kg, .5-1.5h half life. metabolism via CYP450. active metabolite 4-hydroxypropofol. clearance 30-60ml/kg/min
Etomidate
selective modulator of GABA(A) receptors. pKa 4.3. large Vd 2.2-4.5L/kg. T1/2 2-5h, lasts 8h (corticosteroid effects). metabolized by hydrolysis (phase 1)
Ketamine
NMDA antagonist, Vd 2.5-3L/kg, T1/2 2-3h, demethylation by CYP450 micro enzymes (phase 1), metabolism depends on hepatic BF. pKa 7.5.
dextromorphan
low affinity NMDA antagonist
dexmedetomidine
alpha 2 adrenergic agonist, 2-3h half life
scolpalamine
decreases activity of reticular activating system, anticholinergic
morphine
pKa 7.9, onset 15-30min, only small amount of morphine reaches CNS.
codeine
half life 3-3.5h
meperidine
selective kappa and mu receptor agonist, crosses placenta, 2-4h half life
fentanyl
blocks sympathetic stimulation to surgical response, analgesia. pKa 8.4. large Vd, >80% leaves plasma in <5min. context sensitive half time increases with infusion >2h, longer t1/2 than morphine